Sign Up to like & get recommendations! 0
Published in 2020 at "Lasers in Medical Science"
DOI: 10.1007/s10103-020-03129-5
Abstract: Central serous chorioretinopathy (CSC) is a disease characterized by a well-defined serous detachment of the neurosensory retina. Therapeutic options in chronic cases are limited, and side effects can result in a limited response. The aim… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Eye"
DOI: 10.1038/eye.2016.242
Abstract: Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "European journal of ophthalmology"
DOI: 10.1177/1120672120928008
Abstract: PURPOSE To report the safety and efficacy of subthreshold micropulse yellow laser of 577 nm for a complex case of refractory pseudophakic cystoid macular edema. METHODS A retrospective chart review of an interventional case report of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "BMC Ophthalmology"
DOI: 10.1186/s12886-022-02331-z
Abstract: Purpose To compare the efficacy and safety of subthreshold micropulse (STMP) laser photocoagulation and half-dose photodynamic therapy (PDT) in the treatment of acute central serous chorioretinopathy (CSC). Methods A total of 39 acute CSC patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "International Journal of Retina and Vitreous"
DOI: 10.1186/s40942-020-00265-6
Abstract: Background To compare the therapeutic effects of subthreshold micropulse laser (SML) versus intravitreal injection of ranibizumab in treatment of diabetic macular edema (DME) both anatomically using optical coherence tomography (OCT) and functionally using best corrected… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Health technology assessment"
DOI: 10.3310/szki2484
Abstract: BACKGROUND The National Institute for Health and Care Excellence recommends macular laser to treat diabetic macular oedema with a central retinal subfield thickness of 400 µm. MAIN OUTCOME MEASURES The primary outcome was the mean change… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.832448
Abstract: Aim: To examine the effect of subthreshold micropulse yellow laser (SMYL) on best-corrected visual acuity (BCVA), central macular thickness (CMT), and optical coherence tomography angiography (OCT-A) changes in eyes with persistent diabetic macular edema (DME)… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Life"
DOI: 10.3390/life13051194
Abstract: Our study evaluated visual function changes after subthreshold micropulse laser (SML) treatment in persistent central serous chorioretinopathy (CSC) and SML safety profile. We conducted a prospective study including 31 fovea-involving CSC patients. The natural course… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_228_22
Abstract: Purpose: To study the effect of subthreshold micropulse yellow laser treatment on central serous chorioretinopathy (CSC) and to compare two laser protocols. As per our knowledge, there are no studies comparing the two protocols of… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia"
DOI: 10.5507/bp.2022.055
Abstract: AIM The objective of this study was to evaluate the efficacy of diabetic macular edema (DME) therapy using subthreshold micropulse laser (SMPL) with a wavelength of 577 nm during a long-term monitoring period of 5… read more here.